Biotinylated Human HLA-A*24:02&B2M&NY-ESO-1 (LLMWITQCF) Complex Protein (Monomer, MALS verified)
NY-ESO-1, which is also well-known as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancer-testis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLA-A24 restricted NY-ESO-1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatment-refractory melanoma patients. The Human HLA-A*2402 NY-ESO-1 (LLMWITQCF) complex protein is a complex of HLA-A*2402 of the MHC Class I, B2M and LLMWITQCF peptide of the NY-ESO-1.
Product Specifications
Background
Specifications
Accession Number
AAA59600.1 (HLA-A*24:02) & P61769 (B2M) & LLMWITQCF
Expression Region
Gly 25 - Thr 305 (HLA-A*24:02) & Ile 21 - Met 119 (B2M) & LLMWITQCF peptide
Host
HEK293
Target
HLA-A*2402 & B2M & NY-ESO-1 (LLMWITQCF)
Conjugation
Biotin-labeled
Tag
C-10xHis & C-Avi
Source
Human
Stability
The product MUST be stored at -70°C or lower upon receipt; -70°C for 3 months under sterile conditions.
Endotoxin
1.0 EU per μg
Purity
90%
Bioactivity
Format
Liquid
Buffer
PBS, pH7.4
Additives
Trehalose
Molecular Weight
35.8 kDa and 11.7 kDa
Additionnal Information
Please see 'Shipping-and-Payments' sheet. Website: https://www.acrobiosystems.com/support/shipping-and-payments
Shipping Conditions
Dry ice
Storage Conditions
-70°C
Package Size
25ug*1
Host or Source
HEK293
Species
Human
Protein ID
AAA59600.1 (HLA-A*24:02) & P61769 (B2M) & LLMWITQCF
Preservative
Trehalose
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items